DiscoverWTR Small-Cap SpotlightEpisode #142: CEO Brent Lucas on Why Envoy Medical's Device Technology is Currently the Only Change Agent in Hearing Health
Episode #142: CEO Brent Lucas  on Why  Envoy Medical's Device Technology  is Currently the Only Change Agent in Hearing Health

Episode #142: CEO Brent Lucas on Why Envoy Medical's Device Technology is Currently the Only Change Agent in Hearing Health

Update: 2025-08-13
Share

Description

Send us a text

CEO Brent Lucas of Envoy Medical (NASDAQ: COCH), an innovative hearing health technology company and sole US-domiciled cochlear implant company  joins the WTR Small-Cap Spotlight podcast to talk about hearing loss, the third most chronic physical condition prevalent in the US, and how  Envoy's innovative device technology can disrupt the hearing solutions market that has long lacked transformative advancements.  Lucas discusses Envoy's two fully implantable hearing solution products, one in the market (Esteem), the only FDA approved middle ear implant for moderate to severe hearing loss, and the other (Acclaim),  a cochlear implant targeting severe to profound hearing loss which is currently in the advanced stages of clinical development (Acclaim), the competitive landscape and the commercial opportunities. 

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode #142: CEO Brent Lucas  on Why  Envoy Medical's Device Technology  is Currently the Only Change Agent in Hearing Health

Episode #142: CEO Brent Lucas on Why Envoy Medical's Device Technology is Currently the Only Change Agent in Hearing Health

Water Tower Research